The Cooper Companies, Inc. $COO Shares Sold by Ameriprise Financial Inc.

Key Points

• Ameriprise Financial Inc. reduced its stake in The Cooper Companies by 41.5%, selling over 1.2 million shares, which left them with 1,704,852 shares valued at approximately $143.8 million.
• The Cooper Companies reported earnings of $0.96 per share for the quarter, surpassing estimates, and had a revenue increase of 6.3% year-over-year, totaling $1 billion.
• Analysts have a mixed perspective on Cooper Companies, with target price adjustments and ratings ranging from "hold" to "overweight", reflecting a current average target price of $96.73.

Ameriprise Financial Inc. trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 41.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,704,852 shares of the medical device company's stock after selling 1,211,101 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.85% of Cooper Companies worth $143,804,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Zions Bancorporation National Association UT purchased a new position in Cooper Companies in the first quarter worth $33,000. City Holding Co. purchased a new position in Cooper Companies in the first quarter worth $34,000. GKV Capital Management Co. Inc. purchased a new position in Cooper Companies in the first quarter worth $40,000. Larson Financial Group LLC grew its holdings in Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. grew its holdings in Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

COO has been the topic of several analyst reports. Robert W. Baird cut their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a report on Friday, May 30th. Piper Sandler reissued an "overweight" rating and set a $105.00 price objective (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Mizuho dropped their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Finally, BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective on the stock in a report on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded up $0.18 during trading hours on Tuesday, reaching $73.66. The stock had a trading volume of 4,307,279 shares, compared to its average volume of 1,627,738. The stock's 50 day moving average is $72.35 and its 200 day moving average is $77.91. The firm has a market capitalization of $14.73 billion, a PE ratio of 35.76, a PEG ratio of 1.79 and a beta of 1.00. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company's revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.85 earnings per share. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.